Authors

• Adam Rock (ORCID: https://orcid.org/0000-0002-5859-6965)
• Marianna Koczywas (ORCID: https://orcid.org/0000-0002-1588-6292)
• Puneeth Iyengar (ORCID: https://orcid.org/0000-0003-3740-7915)
• Chul Woo Ahn (ORCID: https://orcid.org/0000-0002-2997-9203)
• Erminia Massarelli (ORCID: https://orcid.org/0000-0001-7798-7286)
• Sawsan Rashdan
• Kenneth D. Westover (ORCID: https://orcid.org/0000-0003-3653-5923)
• Townes A Mickel (ORCID: https://orcid.org/0000-0003-1215-6793)
• David E. Gerber (ORCID: https://orcid.org/0000-0002-7812-6741)
• Yuanyuan Zhang (ORCID: https://orcid.org/0000-0001-9230-7314)
• Arya Amini
• Suzanne Cole (ORCID: https://orcid.org/0000-0001-8390-6315)
• Jonathan E. Dowell (ORCID: https://orcid.org/0000-0002-0202-9697)
• Song Zhang (ORCID: https://orcid.org/0000-0002-9364-4053)
• Sagus Sampath (ORCID: https://orcid.org/0000-0002-5464-7446)
• Ang Gao (ORCID: https://orcid.org/0000-0001-6530-8768)

Institutions

• City Of Hope National Medical Center (US)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

EClinicalMedicine

Published

2025-08-26

DOI

https://doi.org/10.1016/j.eclinm.2025.103435

Citations

5

Primary Topic

Lung Cancer Treatments and Mutations

Type

article

Field-Weighted Citation Impact

7.59

Funders

• AstraZeneca
• American Society of Clinical Oncology
• University of Texas Southwestern Medical Center
• National Cancer Institute